361 related articles for article (PubMed ID: 11994520)
1. Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y
J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520
[TBL] [Abstract][Full Text] [Related]
2. Testicular lymphoma with bone/bone marrow metastases illustrated by scrotal sonography, spinal MRI, and total body Tc-99m HMDP and Tc-99m MIBI images.
Shih WJ; Kwolek DS; Lahr B
Ann Nucl Med; 1999 Oct; 13(5):293-7. PubMed ID: 10582797
[TBL] [Abstract][Full Text] [Related]
3. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma.
Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J
Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of 99mTc-MIBI and 99mTc-HMDP scintimammography for the diagnosis of breast cancer and its axillary metastases.
Nishiyama Y; Yamamoto Y; Ono Y; Irie A; Yamauchi A; Satoh K; Ohkawa M
Eur J Nucl Med; 2001 Apr; 28(4):522-8. PubMed ID: 11357504
[TBL] [Abstract][Full Text] [Related]
5. Value of Tc-99m sestamibi scintigraphy in the detection of bone lesions in multiple myeloma: comparison with Tc-99m methylene diphosphonate.
Alexandrakis MG; Kyriakou DS; Passam F; Koukouraki S; Karkavitsas N
Ann Hematol; 2001 Jun; 80(6):349-53. PubMed ID: 11475149
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary application of 99Tc(m)-MIBI scintigraphy for judgment of bone malignant and benign lesions].
Jia ZY; Deng HF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):689-92. PubMed ID: 17718443
[TBL] [Abstract][Full Text] [Related]
7. Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP.
Caner B; Kitapçl M; Unlü M; Erbengi G; Calikoğlu T; Göğüş T; Bekdik C
J Nucl Med; 1992 Mar; 33(3):319-24. PubMed ID: 1531501
[TBL] [Abstract][Full Text] [Related]
8. 99mTc-MIBI scintigraphy in untreated stage III multiple myeloma: comparison with X-ray skeletal survey and bone scintigraphy.
Alper E; Gurel M; Evrensel T; Ozkocaman V; Akbunar T; Demiray M
Nucl Med Commun; 2003 May; 24(5):537-42. PubMed ID: 12717071
[TBL] [Abstract][Full Text] [Related]
9. Tc-99m MIBI uptake in traumatic vertebral fractures and metastatic vertebral lesions: comparison with Tc-99m MDP.
Buyukdereli G; Ermin T; Kara O; Kibar M
Adv Ther; 2006; 23(1):33-8. PubMed ID: 16644620
[TBL] [Abstract][Full Text] [Related]
10. Tc-99m MIBI localization in bone marrow: a marker of bone marrow malignancy.
Wakasugi S; Teshima H; Nakamura H; Hashizume T; Maeda T; Hiraoka A; Hasegawa Y; Masaoka T
Clin Nucl Med; 1998 Oct; 23(10):664-71. PubMed ID: 9790040
[TBL] [Abstract][Full Text] [Related]
11. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
Balleari E; Villa G; Garrè S; Ghirlanda P; Agnese G; Carletto M; Clavio M; Ferrando F; Gobbi M; Mariani G; Ghio R
Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
[TBL] [Abstract][Full Text] [Related]
12. (89)Sr bremsstrahlung single photon emission computed tomography using a gamma camera for bone metastases.
Ota S; Uno M; Kato M; Ishiguro M; Natsume T; Kikukawa K; Tadokoro M; Ichihara T; Toyama H
Ann Nucl Med; 2014 Feb; 28(2):112-9. PubMed ID: 24297387
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of technetium-99m hydroxymethylene diphosphonate scans in localizing bone metastases of differentiated thyroid carcinoma.
Tenenbaum F; Schlumberger M; Bonnin F; Lumbroso J; Aubert B; Benali H; Parmentier C
Eur J Nucl Med; 1993 Dec; 20(12):1168-74. PubMed ID: 8299652
[TBL] [Abstract][Full Text] [Related]
14. Study of the Usefulness of Bone Scan Index Calculated From 99m-Technetium- Hydroxymethylene Diphosphonate (
Higashiyama S; Yoshida A; Kawabe J
Curr Med Imaging; 2021; 17(1):89-96. PubMed ID: 32484112
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma.
Miyamoto S; Kasagi K; Misaki T; Alam MS; Konishi J
J Nucl Med; 1997 Mar; 38(3):352-6. PubMed ID: 9074516
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of (99m)Tc-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with X-rays mammography, ultrasonography and magnetic resonance imaging.
Ozülker T; Ozülker F; Ozpaçaci T; Bender O; Değirmenci H
Hell J Nucl Med; 2010; 13(2):144-9. PubMed ID: 20808988
[TBL] [Abstract][Full Text] [Related]
17. Role of 99mTc-hexakis-2-methoxyisobutylisonitrile for detecting marrow metastases in childhood solid tumours.
Berberoğlu K; Unal SN; Kebudi R; Türkmen C; Cantez S
Nucl Med Commun; 2005 Dec; 26(12):1075-80. PubMed ID: 16264353
[TBL] [Abstract][Full Text] [Related]
18. Intraindividual Comparison of
Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
20. Ring appearance of Tc-99m MIBI thoracic SPECTs and increased uptake on Tc-99m HMDP thoracic SPECTs in a pulmonary mass of small cell carcinoma.
Shih WJ; Turturro F; Stipp V; DeSimone P
Ann Nucl Med; 1996 Nov; 10(4):425-8. PubMed ID: 9006728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
